... commenting / replying to Opel's earlier post this morningYup...

... commenting / replying to Opel's earlier post this morning

Yup potential an equity stake ... but not in Anteotech, but in one of its subsidiaries instead, either Energy (most likely) or possibility Life Sciences.

The only thing is, if its a large EV company they will want a decent stake, which some shareholders may not be happy with.
I can't see an EV company wanting 5 or 10% - more like 20%.

However by taking a stake in a unlisted subsidiary, there should be some independent valuations done as to its worth, so Anteo Energy's tech should be compared to other companies in a similar market (eg Sila) by independent parties. This should see AnteoEnergy valued potentially alot more than its parent AnteoTech.

If a deal was done then AnteoTechs shareprice should re-rate to a value you'd think close or higher than the valuation implied to AnteoEnergy.
Also if its done for a 10 or 20% stake this should see a sizeable cash injection into the company.
And also there would be no dilution of ADO shares as the partner would take a stake in an unlisted subsidiary

As noting the below ....

[1]







"Targeted" Support from partners - sounds like support to one specific (or targeted) area of the business - eg Energy (or Life Sciences), so potentially a stake in a subsidiary.



[2]
The Going concern statement in the Annual Report has changed from the use of the phase "Capital raises" to "Capital injection"
Now Capital Injection to me seems more like funding from 1 or more partners rather than the market.


AR 2024

AR2023


[3]
The Consolidated Entity Statement below, and breakdown in AR 2024 (noting current ownership of the subsidiary companies) wasn't in last years statements.
Yes note 28 on subsidiaries appears in both years but the below statement after the notes to accounts is an added and new section in AR2024